167 related articles for article (PubMed ID: 33123002)
1. An Integrative Serum Pharmacology-Based Approach to Study the Anti-Tumor Activity of
Feng X; Ma G; Shi H; Wang Y; Chao X
Front Pharmacol; 2020; 11():01261. PubMed ID: 33123002
[TBL] [Abstract][Full Text] [Related]
2. Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma.
Wang LL; Liao C; Li XQ; Dai R; Ren QW; Shi HL; Wang XP; Feng XS; Chao X
Med Sci Monit; 2021 Jan; 27():e927624. PubMed ID: 33436534
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: An integrative serum pharmacology-based approach to study the anti-tumor activity of B. Paniculatum aqueous bulb extract on the human hepatocellular carcinoma cell line BEL-7404.
Feng X; Ma G; Shi H; Wang Y; Chao X
Front Pharmacol; 2022; 13():1054143. PubMed ID: 36425573
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Pharmacological Mechanism of the Herb
Feng X; Shi H; Chao X; Zhao F; Song L; Wei M; Zhang H
Front Pharmacol; 2019; 10():253. PubMed ID: 30936832
[TBL] [Abstract][Full Text] [Related]
5. Bioassay-guided isolation and identification of cytotoxic compounds from Bolbostemma paniculatum.
Tang Y; Li W; Cao J; Li W; Zhao Y
J Ethnopharmacol; 2015 Jul; 169():18-23. PubMed ID: 25882313
[TBL] [Abstract][Full Text] [Related]
6. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
7. Bolbostemma paniculatum (Maxim.) Franquet extract suppresses the development of colorectal cancer through downregulation of PI3K/Akt pathway.
Li Y; Sun Y; Zhang Q; Liu Y; Niu Y; Li X; Cai D
J Ethnopharmacol; 2022 Apr; 287():114937. PubMed ID: 34958876
[TBL] [Abstract][Full Text] [Related]
8. A Network Pharmacology Approach to Reveal the Underlying Mechanisms of
Zhang S; Mo Z; Zhang S; Li X
Evid Based Complement Alternat Med; 2021; 2021():8947304. PubMed ID: 33688369
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma.
Zhou R; Wu K; Su M; Li R
Environ Toxicol Pharmacol; 2019 Aug; 70():103200. PubMed ID: 31158732
[TBL] [Abstract][Full Text] [Related]
10. Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking.
Khan SA; Lee TKW
Front Pharmacol; 2022; 13():968148. PubMed ID: 35959427
[TBL] [Abstract][Full Text] [Related]
11. A systematic approach to decode the mechanism of Cornus in the treatment of hepatocellular carcinoma (HCC).
Shen HY; Li XQ; Fan WQ; Wang YW; Huang F; Wu JQ; Zhang W; Feng XS; Chao X
Eur J Pharmacol; 2021 Oct; 909():174405. PubMed ID: 34384755
[TBL] [Abstract][Full Text] [Related]
12. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
Zhang G; Zeng X; Zhang R; Liu J; Zhang W; Zhao Y; Zhang X; Wu Z; Tan Y; Wu Y; Du B
Phytomedicine; 2016 Nov; 23(12):1329-1336. PubMed ID: 27765352
[TBL] [Abstract][Full Text] [Related]
13. Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the
Jiang N; Li H; Sun Y; Zeng J; Yang F; Kantawong F; Wu J
Front Pharmacol; 2021; 12():618522. PubMed ID: 33746755
[No Abstract] [Full Text] [Related]
14. Chinese endemic medicinal plant
Zhou Y; Liu J; Zhang J; Xu Y; Li W; Gao P; Xing Y; Huang L; Qin X; Jin S
Front Pharmacol; 2022; 13():974054. PubMed ID: 36160391
[No Abstract] [Full Text] [Related]
15. A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology.
Yin X; Li J; Hao Z; Ding R; Qiao Y
Front Cell Infect Microbiol; 2022; 12():964469. PubMed ID: 36046748
[TBL] [Abstract][Full Text] [Related]
16. [Study on molecular mechanism of Solanum nigrum in treatment of hepatocarcinoma based on network pharmacology and molecular docking].
Liu JH; Lyu DY; Zhou HM; Kuang WH; Chen ZX; Zhang SJ
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):163-168. PubMed ID: 32237426
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment.
Tang Y; Sun L; Wei J; Sun C; Gan C; Xie X; Liang C; Peng C; Wu H; Zheng Z; Pan Z; Huang Y
J Ethnopharmacol; 2022 Oct; 297():115479. PubMed ID: 35777610
[TBL] [Abstract][Full Text] [Related]
18. The potential mechanism of Chebulae Fructus in the treatment of hepatocellular carcinoma on the basis of network pharmacology.
Jiang J; Yang Z; Hou G; Yao X; Jiang J
Ann Hepatol; 2022; 27(4):100701. PubMed ID: 35351639
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Mechanisms of Arsenic Trioxide (
Wang X; Cao L; Wu J; Zhu G; Zhu X; Zhang X; Han D; Shui N; Ni B; Li J
Evid Based Complement Alternat Med; 2021; 2021():5773802. PubMed ID: 34880920
[TBL] [Abstract][Full Text] [Related]
20. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
